We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$355M
AUM Growth
+$88M
Cap. Flow
-$58.3M
Cap. Flow %
-16.41%
Top 10 Hldgs %
58.86%
Holding
966
New
409
Increased
69
Reduced
50
Closed
347
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLAT
826
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
-500
Closed -$5K
ADAL
827
DELISTED
Anthemis Digital Acquisitions I Corp Class A Ordinary Shares
ADAL
-125
Closed -$1K
OSH
828
DELISTED
Oak Street Health, Inc.
OSH
-146
Closed -$4K
EUCR
829
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
-500
Closed -$5K
HZON
830
DELISTED
Horizon Acquisition Corporation II
HZON
-2,670
Closed -$27K
BMAQ
831
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
-500
Closed -$5K
IPVI
832
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
-49,500
Closed -$487K
PANA
833
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
-496
Closed -$5K
TCVA
834
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
-288
Closed -$3K
TWNI
835
DELISTED
Tailwind International Acquisition Corp.
TWNI
-5,500
Closed -$55K
MSDA
836
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
-514
Closed -$5K
DGNU
837
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
-29,200
Closed -$286K
GXII
838
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
-1,400
Closed -$14K
SMIHU
839
DELISTED
Summit Healthcare Acquisition Corp. Units
SMIHU
-75,000
Closed -$739K
ACQRU
840
DELISTED
Independence Holdings Corp. Units
ACQRU
-75,000
Closed -$744K
PDOT
841
DELISTED
Peridot Acquisition Corp. II
PDOT
-1,544
Closed -$15K
IBER
842
DELISTED
Ibere Pharmaceuticals
IBER
-500
Closed -$5K
COUP
843
DELISTED
Coupa Software Incorporated
COUP
-79
Closed -$5K
NVSA
844
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
-520
Closed -$5K
MCAE
845
DELISTED
Mountain Crest Acquisition Corp. III Common Stock
MCAE
-1,055
Closed -$10K
IPAXU
846
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
-25,000
Closed -$249K
DTRT
847
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
-50,000
Closed -$508K
DNZ
848
DELISTED
D and Z Media Acquisition Corp.
DNZ
-2,000
Closed -$20K
FOXW
849
DELISTED
FoxWayne Enterprises Acquisition Corp. Class A Common Stock
FOXW
-100
Closed -$1K
GIAC
850
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
-500
Closed -$5K

Similar funds

Elequin Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Elequin Capital held 966 positions worth $355M, up 33% from $267M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Elequin Capital withdrew a net $58.3M in Q4 2022, closing 347 positions and reducing 50 holdings. Its most notable exit was Stanley Black & Decker, Inc., an estimated $41.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Elequin Capital opened a new position in State Street SPDR Bloomberg Convertible Securities ETF worth $9.9M.

  • Elequin Capital's largest Q4 2022 buy was State Street SPDR Bloomberg Convertible Securities ETF: 153,900 shares worth $9.9M.
  • Elequin Capital added most to Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q4 2022, an estimated $3.26M increase.
  • Elequin Capital's biggest Q4 2022 reduction was South Jersey Industries, Inc. Corporate Units, cutting an estimated $29.4M.
  • Elequin Capital fully exited Stanley Black & Decker, Inc. in Q4 2022, selling an estimated $41.1M.
  • Elequin Capital's ten largest holdings make up 59% of its $355M portfolio in Q4 2022.
  • Elequin Capital opened 409 new positions and closed 347 in Q4 2022.
  • Elequin Capital's portfolio value rose 33% quarter-over-quarter to $355M.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.